EFMH
LEGN icon

E Fund Management (HK)’s Legend Biotech LEGN Stock Holding History

E Fund Management (HK)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$815K Sell
28,209
-1,713
-6% -$46.2K 0.27% 60
2026
Q1 		$541K Hold
29,922
– – 0.25% 63
2025
Q4 		$513K Hold
29,922
– – 0.17% 65
2025
Q3 		$976K Buy
29,922
+3,790
+15% +$140K 0.59% 28
2025
Q2 		$927K Sell
26,132
-3,796
-13% -$123K 0.89% 14
2025
Q1 		$1.01M Sell
29,928
-13,152
-31% -$472K 0.91% 15
2024
Q4 		$1.4M Sell
43,080
-10,630
-20% -$440K 1.12% 15
2024
Q3 		$2.62M Sell
53,710
-4,716
-8% -$251K 1.56% 12
2024
Q2 		$2.59M Buy
58,426
+1,374
+2% +$63.4K 1.59% 14
2024
Q1 		$3.2M Sell
57,052
-6,845
-11% -$413K 2.1% 12
2023
Q4 		$3.85M Buy
63,897
+11,138
+21% +$706K 2.06% 12
2023
Q3 		$3.54M Buy
52,759
+1,080
+2% +$75K 2.23% 10
2023
Q2 		$3.57M Sell
51,679
-3,234
-6% -$211K 2.66% 9
2023
Q1 		$2.65M Buy
54,913
+21,880
+66% +$1.07M 1.48% 15
2022
Q4 		$1.65M Buy
33,033
+24
+0.1% +$1.16K 1.4% 14
2022
Q3 		$1.35M Buy
33,009
+1,565
+5% +$73.5K 1.07% 21
2022
Q2 		$1.73M Buy
31,444
+4,921
+19% +$208K 1.19% 19
2022
Q1 		$1.08M Buy
26,523
+17,596
+197% +$695K 0.69% 25
2021
Q4 		$416K Buy
+8,927
New +$453K 0.23% 29

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

E Fund Management (HK)'s LEGN Position: Q2 2026 in Review

E Fund Management (HK) reduced its Legend Biotech (LEGN) stake by 5.7% in Q2 2026, selling an estimated $46.2K and leaving 28,209 shares worth $815K. The position accounts for 0.27% of the portfolio, ranked #60.

E Fund Management (HK) first reported a position in LEGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.85M in Q4 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • E Fund Management (HK) held 28,209 shares of Legend Biotech worth $815K as of Q2 2026.
  • E Fund Management (HK) sold 1,713 Legend Biotech shares in Q2 2026, an estimated $46.2K.
  • Legend Biotech made up 0.27% of E Fund Management (HK)'s portfolio in Q2 2026, its #60 holding.
  • E Fund Management (HK) first reported a position in Legend Biotech in Q4 2021 and has held it in 19 quarters since.
  • E Fund Management (HK)'s Legend Biotech position peaked at $3.85M in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.